Abstract Chronic overload of the heart is the major cause of left ventricular hypertrophy (LVH) and eventually heart failure. It is generally accepted that autocrine/paracrine factors, such as angiotensin II (Ang II) and endothelin-1 (ET-1) contribute to the development of LVH. Cardiac hypertrophy and failure are characterized by attenuated responsiveness to β- adrenergic stimulation and accumulation of collagenous material to the left ventricular wall. The present study aimed to characterize the roles of ET-1 and Ang II in the regulation of cardiac function. The role of the plasmamembrane Ca2+-ATPase (PMCA) in ET-1 induced cardiac responses and the role of type XV collagen in cardiac function were also studied. Both ET-1 infusion and mechanical loading were able to induce positive inotropic effect and induction of early response genes in isolated perfused hearts. ET-1 also induced strong vasoconstriction. Cardiomyocyte-specific PMCA overexpression inhibited the ET-1 induced hypertrophic response, while inotropic response remained unaltered. ET-1 was found to induce release of adrenomedullin (AM), a potent vasorelaxing and inotropic peptide. Infusion of AM antagonized the vasoconstrictive effect of ET-1 independently of nitric oxide. In hypertrophied rat hearts ET-1 was found to contribute significantly to the Frank-Starling response, a fundamental mechanism regulating contractile performance of the heart. In mice hearts, ET-1 was found to play a dual role in load induced elevation of contractile strength: ETA receptors mediated an increase, while ETB receptors mediated an inhibitory effect on contrcatile force. Ang II was not contributing to the contractile response to load in either rat or mice hearts. Blunted response to β-adrenergic stimulus and increased vulnerability as a result of exercise was observed in mice lacking collagen XV. In conclusion, the present results underscore the importance of the local factors, especially ET-1, in regulation of cardiac function, not only in terms of hypertrophic but also in terms of contractile response to load. The results also suggest a role for PMCA in regulation of cardiac function. Lack of type XV collagen was found to result in cardiac dysfunction with many features similar to those of early heart failure.

No description available.

Abstract Cytosolic Ca2+, [Ca2+]I , has a key role in intracellular signalling during excitation-contraction coupling (E-C coupling) in cardiac myocytes. The sarcoplasmic reticulum (SR) is a main intracellular Ca2+ store and the Na+-Ca2+ exchanger (NaCaX) is a major mechanism to extrude Ca2+ for balancing the Ca2+ influx via L-type Ca2+ channels during excitation. Furthermore, [Ca2+]I also affects the configuration of the action potential (AP). The present study, by combination of animal experiments and computer simulations, investigated the roles of [Ca2+]I, SR and NaCaX in cardiac myocytes, in Ca2+-induced Ca2+ release (CICR) and in modulation of APs. The following were studied: (I) the stretch-induced effects on rat atrium and the role of [Ca2+]I in modulation of AP; (II) the role of the SR in modulation in rat atrium by stretch; (III) the role of NaCaX; (IV) the role of [Ca2+]I in modulation of action potential duration (APD) in myocytes with short and long action potential duration. In isolated rat atrial preparations, the physiological or moderate stretch stimulus caused two- phasic rise of developed contraction, rapid and slow phases, accompanied with slow increments of [Ca2+]I and prolongations of action potentials durations in continuous recordings. In sustained stretch, the APD and [Ca2+]I were all increased significantly when intra-atrial pressure increased from 1 to 3 mmHg. In computer simulations, employing a rat atrial model (RA model), it was found that stretch-activated channels and increased Tn C affinity for Ca2+ alone could not produce the changes in the experiments. Only after both mechanisms applied to model cells, the main experimental findings could be mimicked (I). The prolongation of APD induced by stretch in rat atrial preparations was reversed after depleting the Ca2+ content of the SR by application of the SR functional inhibitors, ryanodine, thapsigargin and caffeine (II). In the computer simulation using modified guinea pig ventricular model, the Ca2+ entry via the reversal of NaCaX was found to be accounting 25% of the total activator Ca2+ for triggering Ca2+ release from the SR during normal excitation. This contribution increases with elevated [Na+]i (III). In a guinea pig ventricular model (GPV model) and a RA model were employed for investigating the regulation of APD by [Ca2+]I-dependent membrane currents. Increased SR Ca2+ content produced an elevated [Ca2+]I in both model cells, leading to prolongation of APD in the RA model but shortening in the GPV model. Increased [Ca2+]I enhances the NaCaX current in the same scale in both models, but inhibits L-type Ca current much more in the GPV model than the RA model (IV). In conclusion, (I) Stretch-induced [Ca2+]I increase prolongs the rat atrial AP by enhancing the NaCaX inward current. Stretch-activated channels (SACs) and increased affinity of TnC for Ca2+ are main general factors responsible for the variety of changes of cardiac muscles induced by stretch. (II) The SR plays a crucial role in the modulation of myocytes by accumulating the additional Ca2+ influx via sarcolemma during stretch. (III) The NaCaX contributes a small part for activator Ca2+ for calcium release from the SR during normal cardiac E-C coupling. However, this contribution is [Na]i-dependent, and in some pathological conditions, it may be a potential factor for cardiac arrhythmogenesis. (IV) Different effects on the NaCaX and L-type channels induced by increased [Ca2+]I leads to the dispersion of the change of APD in myocytes with long and short AP during inotropic interventions that increase the [Ca2+]I.

No description available.

No description available.

No description available.

No description available.

Abstract Melatonin is an important modulator of several physiological and behavioural processes, and it influences the function of many different tissues. Melatonin has effective antioxidative properties, but some of its actions in mammals are also mediated through the MT1 and MT2 melatonin receptors. Antioxidative properties are seen especially when the melatonin concentration is high (≥ nM), and melatonin's affinity for its receptors appears at lower concentrations (pM). Recently, the involvement of melatonin in protecting the heart against cardiac diseases, including myocardial infarction (MI), has been brought out. MI alters the structure and function of myocardium, attenuating for example cardiac contractility by affecting the amount and function of the essential Ca2+ handling proteins, dihydropyridine receptor (DHPR), ryanodine receptor (RyR2) and sarco-endoplasmic reticulum (SR) Ca2+-ATPase2 (SERCA2). MI also evokes many adaptive responses in organisms, such as elevated production of atrial and brain natriuretic peptides (ANP and BNP). In this thesis, the expression of MT1 and MT2 receptor mRNAs was investigated in several rat tissues. Furthermore, the effect of MI and exogenous melatonin on the rat endogenous melatonin and on the expression of cardiac MT1, MT2, DHPR, RyR2 and SERCA2 proteins was evaluated. The concentrations of ANP and BNP were also measured after post-MI melatonin administration. The results show the expression of MT1 and/or MT2 receptor mRNAs in the hypothalamus, retina, small intestine, liver and heart, which indicates that at least some effects of melatonin could be mediated through the receptors in these tissues. Melatonin synthesis in the pineal gland increased rapidly in response to MI, supporting an important role of endogenous melatonin in protecting the heart after MI. Furthermore, exogenous melatonin altered the mRNA expression of DHPR, RyR2 and SERCA2 after MI, suggesting that melatonin might contribute to the post-infarction cardiac contractile function. The results also revealed a novel, positive relationship between melatonin and ANP, and thereby bring out one more possible way of melatonin to protect the heart against MI-induced injuries. Taken together, the present thesis (i) supports the notion that melatonin is an important endogenous protective agent of the organism, and (ii) extends our knowledge of melatonin's post-infarction cardioprotective actions. / Tiivistelmä Melatoniini osallistuu monien fysiologisten toimintojen ja käyttäytymisen säätelyyn sekä vaikuttaa useiden eri kudosten toimintaan. Melatoniini on tehokas antioksidantti, mutta jotkut sen vaikutuksista välittyvät myös MT1 ja MT2 melatoniini reseptorien kautta. Antioksidatiiviset vaikutukset tulevat esiin erityisesti silloin, kun melatoniinin pitoisuus on korkea (≥ nM). Alhaisemmilla pitoisuuksilla (pM) on puolestaan havaittavissa melatoniinin sitoutuminen reseptoreihinsa. Viime aikoina on tullut esille melatoniinin mahdollinen suojavaikutus sydänsairauksia, kuten sydäninfarkteja, vastaan. Sydäninfarkti muuttaa sydänlihaksen rakennetta ja toimintaa esimerkiksi vaikuttamalla supistuksen kannalta välttämättömien proteiinien, dihydropyridiini reseptorin (DHPR), ryanodiini reseptorin (RyR2) ja sarko-endoplasmakalvoston Ca2+-ATPaasi2:n (SERCA2) lukumääriin ja toimintaan, ja sitä kautta muun muassa heikentää sydämen supistuvuutta. Sydäninfarkti laukaisee elimistössä myös monia adaptiivisia vasteita, kuten eteispeptidin (ANP) ja aivojen natriureettisen peptidin (BNP) lisääntyneen erityksen. Tässä väitöstyössä tutkittiin MT1 ja MT2 reseptorien mRNAn ilmentymistä useissa rotan eri kudoksissa. Lisäksi tutkittiin sydäninfarktin ja eksogeenisen melatoniinin vaikutuksia rotan endogeeniseen melatoniiniin sekä sydämen MT1, MT2, DHPR, RyR2 ja SERCA2 proteiinien ekspressioon. Myös ANP ja BNP pitoisuudet mitattiin. Tulokset osoittivat MT1 ja/tai MT2 reseptori mRNAn ilmentymisen hypotalamuksessa, silmän verkkokalvolla, ohutsuolessa, maksassa ja sydämessä, minkä perusteella ainakin osa melatoniinin vaikutuksista saattaisi olla reseptorivälitteisiä näissä kudoksissa. Tulosten mukaan käpyrauhasen melatoniinisynteesi lisääntyi nopeasti sydäninfarktin jälkeen, mikä tukee käsitystä endogeenisen melatoniinin tärkeästä roolista infarktin jälkeisessä sydämen suojauksessa. Lisäksi eksogeeninen melatoniini muutti DHPR:n, RyR2:n ja SERCA2:n mRNA ekspressiota infarktin jälkeen, mikä voisi merkitä, että melatoniini saattaa vaikuttaa infarktin jälkeiseen sydämen supistuvuuteen. Tulosten osoittama positiivinen riippuvuus melatoniinin ja ANP:n välillä tuo puolestaan esille yhden uuden mahdollisen keinon, jonka kautta melatoniini voisi suojata sydäntä infarktin aiheuttamia vaurioita vastaan. Yhteenvetona voidaan todeta, että tämä väitöstyö (i) tukee käsitystä, että endogeenisella melatoniinilla on tärkeä merkitys elimistön suojaamisessa, ja (ii) laajentaa tietämystämme infarktin jälkeisistä melatoniinin sydäntä suojaavista vaikutuksista.